Predicting liver metastasis of gastrointestinal tract cancer by diffusion-weighted imaging of apparent diffusion coefficient values

AIM: To determine if efficacy of chemotherapy on liver metastasis of gastrointestinal tract cancer can be predicted by apparent diffusion coefficient(ADC) values of diffusion-weighted imaging(DWI). METHODS: In total, 86 patients with liver metastasis of gastrointestinal tract cancer(156 metastatic l...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of gastroenterology : WJG Vol. 22; no. 10; pp. 3031 - 3037
Main Authors Zheng, De-Xian, Meng, Shu-Chun, Liu, Qing-Jun, Li, Chuan-Ting, Shang, Xi-Dan, Zhu, Yu-Seng, Bai, Tian-Jun, Xu, Shi-Ming
Format Journal Article
LanguageEnglish
Published United States Baishideng Publishing Group Inc 14.03.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract AIM: To determine if efficacy of chemotherapy on liver metastasis of gastrointestinal tract cancer can be predicted by apparent diffusion coefficient(ADC) values of diffusion-weighted imaging(DWI). METHODS: In total, 86 patients with liver metastasis of gastrointestinal tract cancer(156 metastatic lesions) diagnosed in our hospital were included in this study. The maximum diameters of these tumors were compared with each other before treatment, 2 wk after treatment, and 12 wk after treatment. Selected patients were classified as the effective group and the ineffective group, depending on the maximum diameter of the tumor after 12 wk of treatment; and the ADC values at different treatment times between the two groups were compared. Spearman rank correlation was used to analyze the relationship between ADC value and tumor diameter. Receiver operating characteristic curve(ROC curve) was used to analyze the ADC values before treatment to predict the patient’s sensitivity and specificity degree of efficacy to the chemotherapy. RESULTS: There was no difference in age between the two groups and in maximum tumor diameter before treatment and 2 wk after treatment. However, after 12 wk of treatment, maximum tumor diameter in the effective group was significantly lower than that in the ineffective group(P < 0.05). Before treatment, ADC values in the ineffective group were significantly higher than those in the effective group(P < 0.05). There was no difference in ADC values between the effective and ineffective groups after 2 and 12 wk of treatment. However, ADC values were significantly higher after 2 and 12 wk of treatment compared to before treatment in the effective group(P < 0.05). Spearman rank correlation analysis showed that ADC value before treatment and the reduced percentage of the maximum tumor diameter after 12 wk of treatment were negatively correlated, while the increase in the percentage of the ADC value 12 wk after treatment and the decrease in the percentage of the maximum tumor diameter were significantly positively correlated. The results of the ROC curve showed that ADC value with a chemotherapy ineffective threshold value of 1.14 × 10-3 mm2/s before treatment had a sensitivity and specificity of 94.3% and 76.7%, respectively. CONCLUSION: DWI ADC values can be used to predict the response of patients with liver metastasis of gastrointestinal tract cancer to chemotherapy with high sensitivity and relatively high specificity.
AbstractList To determine if efficacy of chemotherapy on liver metastasis of gastrointestinal tract cancer can be predicted by apparent diffusion coefficient (ADC) values of diffusion-weighted imaging (DWI).AIMTo determine if efficacy of chemotherapy on liver metastasis of gastrointestinal tract cancer can be predicted by apparent diffusion coefficient (ADC) values of diffusion-weighted imaging (DWI).In total, 86 patients with liver metastasis of gastrointestinal tract cancer (156 metastatic lesions) diagnosed in our hospital were included in this study. The maximum diameters of these tumors were compared with each other before treatment, 2 wk after treatment, and 12 wk after treatment. Selected patients were classified as the effective group and the ineffective group, depending on the maximum diameter of the tumor after 12 wk of treatment; and the ADC values at different treatment times between the two groups were compared. Spearman rank correlation was used to analyze the relationship between ADC value and tumor diameter. Receiver operating characteristic curve (ROC curve) was used to analyze the ADC values before treatment to predict the patient's sensitivity and specificity degree of efficacy to the chemotherapy.METHODSIn total, 86 patients with liver metastasis of gastrointestinal tract cancer (156 metastatic lesions) diagnosed in our hospital were included in this study. The maximum diameters of these tumors were compared with each other before treatment, 2 wk after treatment, and 12 wk after treatment. Selected patients were classified as the effective group and the ineffective group, depending on the maximum diameter of the tumor after 12 wk of treatment; and the ADC values at different treatment times between the two groups were compared. Spearman rank correlation was used to analyze the relationship between ADC value and tumor diameter. Receiver operating characteristic curve (ROC curve) was used to analyze the ADC values before treatment to predict the patient's sensitivity and specificity degree of efficacy to the chemotherapy.There was no difference in age between the two groups and in maximum tumor diameter before treatment and 2 wk after treatment. However, after 12 wk of treatment, maximum tumor diameter in the effective group was significantly lower than that in the ineffective group (P < 0.05). Before treatment, ADC values in the ineffective group were significantly higher than those in the effective group (P < 0.05). There was no difference in ADC values between the effective and ineffective groups after 2 and 12 wk of treatment. However, ADC values were significantly higher after 2 and 12 wk of treatment compared to before treatment in the effective group (P < 0.05). Spearman rank correlation analysis showed that ADC value before treatment and the reduced percentage of the maximum tumor diameter after 12 wk of treatment were negatively correlated, while the increase in the percentage of the ADC value 12 wk after treatment and the decrease in the percentage of the maximum tumor diameter were significantly positively correlated. The results of the ROC curve showed that ADC value with a chemotherapy ineffective threshold value of 1.14 × 10(-3) mm(2)/s before treatment had a sensitivity and specificity of 94.3% and 76.7%, respectively.RESULTSThere was no difference in age between the two groups and in maximum tumor diameter before treatment and 2 wk after treatment. However, after 12 wk of treatment, maximum tumor diameter in the effective group was significantly lower than that in the ineffective group (P < 0.05). Before treatment, ADC values in the ineffective group were significantly higher than those in the effective group (P < 0.05). There was no difference in ADC values between the effective and ineffective groups after 2 and 12 wk of treatment. However, ADC values were significantly higher after 2 and 12 wk of treatment compared to before treatment in the effective group (P < 0.05). Spearman rank correlation analysis showed that ADC value before treatment and the reduced percentage of the maximum tumor diameter after 12 wk of treatment were negatively correlated, while the increase in the percentage of the ADC value 12 wk after treatment and the decrease in the percentage of the maximum tumor diameter were significantly positively correlated. The results of the ROC curve showed that ADC value with a chemotherapy ineffective threshold value of 1.14 × 10(-3) mm(2)/s before treatment had a sensitivity and specificity of 94.3% and 76.7%, respectively.DWI ADC values can be used to predict the response of patients with liver metastasis of gastrointestinal tract cancer to chemotherapy with high sensitivity and relatively high specificity.CONCLUSIONDWI ADC values can be used to predict the response of patients with liver metastasis of gastrointestinal tract cancer to chemotherapy with high sensitivity and relatively high specificity.
AIM: To determine if efficacy of chemotherapy on liver metastasis of gastrointestinal tract cancer can be predicted by apparent diffusion coefficient(ADC) values of diffusion-weighted imaging(DWI). METHODS: In total, 86 patients with liver metastasis of gastrointestinal tract cancer(156 metastatic lesions) diagnosed in our hospital were included in this study. The maximum diameters of these tumors were compared with each other before treatment, 2 wk after treatment, and 12 wk after treatment. Selected patients were classified as the effective group and the ineffective group, depending on the maximum diameter of the tumor after 12 wk of treatment; and the ADC values at different treatment times between the two groups were compared. Spearman rank correlation was used to analyze the relationship between ADC value and tumor diameter. Receiver operating characteristic curve(ROC curve) was used to analyze the ADC values before treatment to predict the patient’s sensitivity and specificity degree of efficacy to the chemotherapy. RESULTS: There was no difference in age between the two groups and in maximum tumor diameter before treatment and 2 wk after treatment. However, after 12 wk of treatment, maximum tumor diameter in the effective group was significantly lower than that in the ineffective group(P &lt; 0.05). Before treatment, ADC values in the ineffective group were significantly higher than those in the effective group(P &lt; 0.05). There was no difference in ADC values between the effective and ineffective groups after 2 and 12 wk of treatment. However, ADC values were significantly higher after 2 and 12 wk of treatment compared to before treatment in the effective group(P &lt; 0.05). Spearman rank correlation analysis showed that ADC value before treatment and the reduced percentage of the maximum tumor diameter after 12 wk of treatment were negatively correlated, while the increase in the percentage of the ADC value 12 wk after treatment and the decrease in the percentage of the maximum tumor diameter were significantly positively correlated. The results of the ROC curve showed that ADC value with a chemotherapy ineffective threshold value of 1.14 × 10-3 mm2/s before treatment had a sensitivity and specificity of 94.3% and 76.7%, respectively. CONCLUSION: DWI ADC values can be used to predict the response of patients with liver metastasis of gastrointestinal tract cancer to chemotherapy with high sensitivity and relatively high specificity.
AIM: To determine if efficacy of chemotherapy on liver metastasis of gastrointestinal tract cancer can be predicted by apparent diffusion coefficient (ADC) values of diffusion-weighted imaging (DWI). METHODS: In total, 86 patients with liver metastasis of gastrointestinal tract cancer (156 metastatic lesions) diagnosed in our hospital were included in this study. The maximum diameters of these tumors were compared with each other before treatment, 2 wk after treatment, and 12 wk after treatment. Selected patients were classified as the effective group and the ineffective group, depending on the maximum diameter of the tumor after 12 wk of treatment; and the ADC values at different treatment times between the two groups were compared. Spearman rank correlation was used to analyze the relationship between ADC value and tumor diameter. Receiver operating characteristic curve (ROC curve) was used to analyze the ADC values before treatment to predict the patient’s sensitivity and specificity degree of efficacy to the chemotherapy. RESULTS: There was no difference in age between the two groups and in maximum tumor diameter before treatment and 2 wk after treatment. However, after 12 wk of treatment, maximum tumor diameter in the effective group was significantly lower than that in the ineffective group ( P < 0.05). Before treatment, ADC values in the ineffective group were significantly higher than those in the effective group ( P < 0.05). There was no difference in ADC values between the effective and ineffective groups after 2 and 12 wk of treatment. However, ADC values were significantly higher after 2 and 12 wk of treatment compared to before treatment in the effective group ( P < 0.05). Spearman rank correlation analysis showed that ADC value before treatment and the reduced percentage of the maximum tumor diameter after 12 wk of treatment were negatively correlated, while the increase in the percentage of the ADC value 12 wk after treatment and the decrease in the percentage of the maximum tumor diameter were significantly positively correlated. The results of the ROC curve showed that ADC value with a chemotherapy ineffective threshold value of 1.14 × 10 -3 mm 2 /s before treatment had a sensitivity and specificity of 94.3% and 76.7%, respectively. CONCLUSION: DWI ADC values can be used to predict the response of patients with liver metastasis of gastrointestinal tract cancer to chemotherapy with high sensitivity and relatively high specificity.
To determine if efficacy of chemotherapy on liver metastasis of gastrointestinal tract cancer can be predicted by apparent diffusion coefficient (ADC) values of diffusion-weighted imaging (DWI). In total, 86 patients with liver metastasis of gastrointestinal tract cancer (156 metastatic lesions) diagnosed in our hospital were included in this study. The maximum diameters of these tumors were compared with each other before treatment, 2 wk after treatment, and 12 wk after treatment. Selected patients were classified as the effective group and the ineffective group, depending on the maximum diameter of the tumor after 12 wk of treatment; and the ADC values at different treatment times between the two groups were compared. Spearman rank correlation was used to analyze the relationship between ADC value and tumor diameter. Receiver operating characteristic curve (ROC curve) was used to analyze the ADC values before treatment to predict the patient's sensitivity and specificity degree of efficacy to the chemotherapy. There was no difference in age between the two groups and in maximum tumor diameter before treatment and 2 wk after treatment. However, after 12 wk of treatment, maximum tumor diameter in the effective group was significantly lower than that in the ineffective group (P < 0.05). Before treatment, ADC values in the ineffective group were significantly higher than those in the effective group (P < 0.05). There was no difference in ADC values between the effective and ineffective groups after 2 and 12 wk of treatment. However, ADC values were significantly higher after 2 and 12 wk of treatment compared to before treatment in the effective group (P < 0.05). Spearman rank correlation analysis showed that ADC value before treatment and the reduced percentage of the maximum tumor diameter after 12 wk of treatment were negatively correlated, while the increase in the percentage of the ADC value 12 wk after treatment and the decrease in the percentage of the maximum tumor diameter were significantly positively correlated. The results of the ROC curve showed that ADC value with a chemotherapy ineffective threshold value of 1.14 × 10(-3) mm(2)/s before treatment had a sensitivity and specificity of 94.3% and 76.7%, respectively. DWI ADC values can be used to predict the response of patients with liver metastasis of gastrointestinal tract cancer to chemotherapy with high sensitivity and relatively high specificity.
Author De-Xian Zheng Shu-Chun Meng Qing-Jun Liu Chuan-Ting Li Xi-Dan Shang Yu-Seng Zhu Tian-Jun Bai Shi-Ming Xu
AuthorAffiliation Department of Radiology,Second People’s Hospital of Liaocheng City;Department of Radiology,Third People’s Hospital of Liaocheng city;Medical Imaging Institute of Shandong Province,Shandong Provincial Hospital;Department of Gastroenterology,Second People’s Hospital of Liaocheng city;Department of Radiology,People’s Hospital of Liaocheng city
Author_xml – sequence: 1
  givenname: De-Xian
  surname: Zheng
  fullname: Zheng, De-Xian
– sequence: 2
  givenname: Shu-Chun
  surname: Meng
  fullname: Meng, Shu-Chun
– sequence: 3
  givenname: Qing-Jun
  surname: Liu
  fullname: Liu, Qing-Jun
– sequence: 4
  givenname: Chuan-Ting
  surname: Li
  fullname: Li, Chuan-Ting
– sequence: 5
  givenname: Xi-Dan
  surname: Shang
  fullname: Shang, Xi-Dan
– sequence: 6
  givenname: Yu-Seng
  surname: Zhu
  fullname: Zhu, Yu-Seng
– sequence: 7
  givenname: Tian-Jun
  surname: Bai
  fullname: Bai, Tian-Jun
– sequence: 8
  givenname: Shi-Ming
  surname: Xu
  fullname: Xu, Shi-Ming
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26973399$$D View this record in MEDLINE/PubMed
BookMark eNp9UctqHDEQFMEhXm9yzynomMts9JrR6BIIxnmAITkkZ6HRSLMys9Ja0q7xOT-eHrx2HocIgZpWVXXRdYHOYooOodeUbLgU_bu7m2lzZGwTlgbh9BlaMUZVw3pBztCKEiIbxZk8Rxel3BDCOG_ZC3TOOiU5V2qFfn7Lbgy2hjjhORxdxjtXTYEbCk4eT1DnFGJ1BTBmxjUbW7E10QJ2uMdj8P5QQorNnQvTtroRh52ZFj2gm_3eZBfrbxi2yXkfbFi6RzMfXHmJnnszF_fq9K7Rj49X3y8_N9dfP325_HDdWCFIbbj0o-yd6AdrrCRqoJ1ouR066axpPXOWU6OU5YwaqVrOCRHDMBJvad9xKvgavX_Q3R-GnRstOMhm1vsMhvO9Tibov39i2OopHbWQUinWgcDbk0BOt2C86l0o1s2ziS4diqZScsEJBVtr9ObPWU9DHjcPgO4BYHMqJTuvbaimwoZgdJg1JXqJWEPEGiLWYWlAxEAk_xAftf9D4SfKNsXpFrJ54ijSL0e1RPRCtUIoeJeq478AT22-rg
CitedBy_id crossref_primary_10_1016_j_ejro_2022_100399
crossref_primary_10_1155_2022_5132135
crossref_primary_10_2478_raon_2021_0052
crossref_primary_10_4254_wjh_v9_i26_1081
crossref_primary_10_1002_adma_202007603
crossref_primary_10_1259_bjr_20181044
crossref_primary_10_1002_jso_26875
crossref_primary_10_24835_1607_0763_2017_6_49_62
Cites_doi 10.1148/radiol.12120167
10.1016/j.jss.2014.07.036
10.1158/1078-0432.CCR-12-2738
10.1093/neuonc/nos314
10.1097/COC.0b013e318209cd8f
10.1016/j.ejphar.2010.09.019
10.1097/MD.0000000000000517
10.1016/S1726-4901(09)70379-X
10.1093/neuonc/not153
10.1007/s10151-013-1069-9
10.1093/jjco/hyr037
10.1002/jmri.23915
10.1016/j.crad.2013.11.005
10.3748/wjg.v20.i7.1650
10.12998/wjcc.v3.i3.231
10.1016/j.mri.2013.12.007
10.1148/radiol.13130866
10.1021/mp300582s
10.1097/COC.0b013e3181a650fb
10.1007/s00104-013-2660-3
10.1097/SMJ.0b013e3181b67356
10.1007/s00330-014-3573-3
10.1002/nbm.3014
10.3748/wjg.v19.i9.1485
10.1148/radiol.14132084
10.1007/s00595-009-4099-1
10.1002/jmri.23804
10.1371/journal.pone.0072679
10.3748/wjg.v20.i5.1180
10.3348/kjr.2013.14.4.616
10.1007/s00261-013-0032-6
10.1148/radiol.13131810
10.3748/wjg.v21.i5.1621
ContentType Journal Article
Copyright The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. 2016
Copyright_xml – notice: The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. 2016
DBID 2RA
92L
CQIGP
~WA
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.3748/wjg.v22.i10.3031
DatabaseName 中文科技期刊数据库
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库- 镜像站点
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Predicting liver metastasis of gastrointestinal tract cancer by diffusion-weighted imaging of apparent diffusion coefficient values
EISSN 2219-2840
EndPage 3037
ExternalDocumentID PMC4779926
26973399
10_3748_wjg_v22_i10_3031
90888889504849544948484956
Genre Journal Article
Comparative Study
Observational Study
GroupedDBID ---
123
29R
2B.
2C~
2RA
2WC
36B
53G
5VR
8WL
92F
92I
92L
93N
93R
AAKDD
ACGFO
AENEX
AFUIB
ALMA_UNASSIGNED_HOLDINGS
CCEZO
CHBEP
CIEJG
CQIGP
CS3
CW9
DIK
DU5
E3Z
EBS
EJD
EMB
F5P
FA0
FRP
GX1
HYE
M~E
OK1
P2P
RNS
RPM
SV3
TCJ
TGQ
TR2
WFFXF
XSB
~WA
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c440t-37fd78e48bcac709b16453cb67eca5f2ec31a99c321a79533004bbd0fc1863143
ISSN 1007-9327
2219-2840
IngestDate Thu Aug 21 17:33:35 EDT 2025
Fri Jul 11 07:35:10 EDT 2025
Thu Jan 02 22:20:17 EST 2025
Tue Jul 01 01:54:10 EDT 2025
Thu Apr 24 22:52:57 EDT 2025
Wed Feb 14 10:13:35 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 10
Keywords Gastrointestinal tract cancer
Chemotherapy
Magnetic resonance imaging
Liver metastatic tumor
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c440t-37fd78e48bcac709b16453cb67eca5f2ec31a99c321a79533004bbd0fc1863143
Notes De-Xian Zheng;Shu-Chun Meng;Qing-Jun Liu;Chuan-Ting Li;Xi-Dan Shang;Yu-Seng Zhu;Tian-Jun Bai;Shi-Ming Xu;Department of Radiology,Second People’s Hospital of Liaocheng City;Department of Radiology,Third People’s Hospital of Liaocheng city;Medical Imaging Institute of Shandong Province,Shandong Provincial Hospital;Department of Gastroenterology,Second People’s Hospital of Liaocheng city;Department of Radiology,People’s Hospital of Liaocheng city
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
Author contributions: Zheng DX and Meng SC designed research; Zheng DX, Meng SC, Liu QJ and Li CT performed research; Meng SC, Liu QJ, Li CT, Shang XD and Zhu YS contributed new reagents/analytic tools; Zheng DX and Meng SC analyzed data; Zheng DX and Meng SC wrote the paper; All the authors contributed to this manuscript.
Telephone: +86-635-8385120
Correspondence to: Shu-Chun Meng, Deputy Chief Physician, Department of Radiology, Third People’s Hospital of Liaocheng city, Shandong No. 62 Weiyu Road of Liaocheng city, 60 Weiyu Road, Liaocheng 252000, Shandong Province, China. zhengdexianx@sina.com
OpenAccessLink https://www.wjgnet.com/1007-9327/full/v22/i10/3031.htm
PMID 26973399
PQID 1773430145
PQPubID 23479
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4779926
proquest_miscellaneous_1773430145
pubmed_primary_26973399
crossref_citationtrail_10_3748_wjg_v22_i10_3031
crossref_primary_10_3748_wjg_v22_i10_3031
chongqing_primary_90888889504849544948484956
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-03-14
PublicationDateYYYYMMDD 2016-03-14
PublicationDate_xml – month: 03
  year: 2016
  text: 2016-03-14
  day: 14
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle World journal of gastroenterology : WJG
PublicationTitleAlternate World Journal of Gastroenterology
PublicationYear 2016
Publisher Baishideng Publishing Group Inc
Publisher_xml – name: Baishideng Publishing Group Inc
References ref13
ref12
ref15
ref14
ref31
ref30
ref11
ref33
ref10
ref32
ref2
ref1
ref17
ref16
ref19
ref18
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref28
ref27
ref29
ref8
ref7
ref9
ref4
ref3
ref6
ref5
24327584 - Neuro Oncol. 2014 Jan;16(1):131-9
23275575 - Neuro Oncol. 2013 Mar;15(3):382-90
23560393 - Mol Pharm. 2013 May 6;10(5):1783-94
24512795 - Magn Reson Imaging. 2014 May;32(4):342-9
23532891 - Clin Cancer Res. 2013 May 1;19(9):2518-27
21336090 - Am J Clin Oncol. 2012 Apr;35(2):158-62
24072381 - Abdom Imaging. 2014 Feb;39(1):2-17
23151830 - Radiology. 2013 Feb;266(2):531-8
24471389 - Radiology. 2014 Feb;270(2):400-8
19738517 - South Med J. 2009 Oct;102(10):1032-40
21459893 - Jpn J Clin Oncol. 2011 Jun;41(6):770-5
24057356 - Tech Coloproctol. 2014 Jun;18(6):521-7
23148046 - J Magn Reson Imaging. 2013 Jul;38(1):206-9
19806036 - Am J Clin Oncol. 2010 Jun;33(3):242-5
23018989 - J Magn Reson Imaging. 2013 Jan;37(1):187-93
24360516 - Clin Radiol. 2014 Apr;69(4):378-84
25145903 - J Surg Res. 2014 Dec;192(2):312-6
25789296 - World J Clin Cases. 2015 Mar 16;3(3):231-44
25663782 - World J Gastroenterol. 2015 Feb 7;21(5):1621-7
20496139 - Surg Today. 2010 Jun;40(6):561-5
24475862 - Radiology. 2014 May;271(2):416-25
24587644 - World J Gastroenterol. 2014 Feb 21;20(7):1650-6
25605133 - Eur Radiol. 2015 Jul;25(7):2033-40
23901319 - Korean J Radiol. 2013 Jul-Aug;14(4):616-25
25674749 - Medicine (Baltimore). 2015 Feb;94(6):e517
24574794 - World J Gastroenterol. 2014 Feb 7;20(5):1180-91
24038282 - NMR Biomed. 2013 Dec;26(12):1762-7
19541568 - J Chin Med Assoc. 2009 Jun;72(6):323-7
24533873 - Radiology. 2014 Jun;271(3):672-80
23538460 - World J Gastroenterol. 2013 Mar 7;19(9):1485-8
24449083 - Chirurg. 2014 Sep;85(9):806-11
20863829 - Eur J Pharmacol. 2010 Dec 15;649(1-3):328-35
23991141 - PLoS One. 2013;8(8):e72679
References_xml – ident: ref18
  doi: 10.1148/radiol.12120167
– ident: ref4
  doi: 10.1016/j.jss.2014.07.036
– ident: ref28
  doi: 10.1158/1078-0432.CCR-12-2738
– ident: ref31
  doi: 10.1093/neuonc/nos314
– ident: ref12
  doi: 10.1097/COC.0b013e318209cd8f
– ident: ref7
  doi: 10.1016/j.ejphar.2010.09.019
– ident: ref9
  doi: 10.1097/MD.0000000000000517
– ident: ref20
  doi: 10.1016/S1726-4901(09)70379-X
– ident: ref26
  doi: 10.1093/neuonc/not153
– ident: ref3
  doi: 10.1007/s10151-013-1069-9
– ident: ref19
  doi: 10.1093/jjco/hyr037
– ident: ref6
  doi: 10.1002/jmri.23915
– ident: ref25
  doi: 10.1016/j.crad.2013.11.005
– ident: ref29
  doi: 10.3748/wjg.v20.i7.1650
– ident: ref1
  doi: 10.12998/wjcc.v3.i3.231
– ident: ref11
  doi: 10.1016/j.mri.2013.12.007
– ident: ref24
  doi: 10.1148/radiol.13130866
– ident: ref17
  doi: 10.1021/mp300582s
– ident: ref15
  doi: 10.1097/COC.0b013e3181a650fb
– ident: ref2
  doi: 10.1007/s00104-013-2660-3
– ident: ref8
  doi: 10.1097/SMJ.0b013e3181b67356
– ident: ref21
  doi: 10.1007/s00330-014-3573-3
– ident: ref27
  doi: 10.1002/nbm.3014
– ident: ref10
  doi: 10.3748/wjg.v19.i9.1485
– ident: ref22
  doi: 10.1148/radiol.14132084
– ident: ref14
  doi: 10.1007/s00595-009-4099-1
– ident: ref33
  doi: 10.1002/jmri.23804
– ident: ref13
  doi: 10.1371/journal.pone.0072679
– ident: ref32
  doi: 10.3748/wjg.v20.i5.1180
– ident: ref16
  doi: 10.3348/kjr.2013.14.4.616
– ident: ref5
  doi: 10.1007/s00261-013-0032-6
– ident: ref23
  doi: 10.1148/radiol.13131810
– ident: ref30
  doi: 10.3748/wjg.v21.i5.1621
– reference: 20863829 - Eur J Pharmacol. 2010 Dec 15;649(1-3):328-35
– reference: 25605133 - Eur Radiol. 2015 Jul;25(7):2033-40
– reference: 24038282 - NMR Biomed. 2013 Dec;26(12):1762-7
– reference: 19541568 - J Chin Med Assoc. 2009 Jun;72(6):323-7
– reference: 25674749 - Medicine (Baltimore). 2015 Feb;94(6):e517
– reference: 20496139 - Surg Today. 2010 Jun;40(6):561-5
– reference: 24587644 - World J Gastroenterol. 2014 Feb 21;20(7):1650-6
– reference: 23538460 - World J Gastroenterol. 2013 Mar 7;19(9):1485-8
– reference: 23148046 - J Magn Reson Imaging. 2013 Jul;38(1):206-9
– reference: 24057356 - Tech Coloproctol. 2014 Jun;18(6):521-7
– reference: 24360516 - Clin Radiol. 2014 Apr;69(4):378-84
– reference: 25145903 - J Surg Res. 2014 Dec;192(2):312-6
– reference: 25789296 - World J Clin Cases. 2015 Mar 16;3(3):231-44
– reference: 24449083 - Chirurg. 2014 Sep;85(9):806-11
– reference: 24327584 - Neuro Oncol. 2014 Jan;16(1):131-9
– reference: 24471389 - Radiology. 2014 Feb;270(2):400-8
– reference: 25663782 - World J Gastroenterol. 2015 Feb 7;21(5):1621-7
– reference: 23991141 - PLoS One. 2013;8(8):e72679
– reference: 21336090 - Am J Clin Oncol. 2012 Apr;35(2):158-62
– reference: 23275575 - Neuro Oncol. 2013 Mar;15(3):382-90
– reference: 24072381 - Abdom Imaging. 2014 Feb;39(1):2-17
– reference: 21459893 - Jpn J Clin Oncol. 2011 Jun;41(6):770-5
– reference: 19806036 - Am J Clin Oncol. 2010 Jun;33(3):242-5
– reference: 23560393 - Mol Pharm. 2013 May 6;10(5):1783-94
– reference: 24574794 - World J Gastroenterol. 2014 Feb 7;20(5):1180-91
– reference: 24475862 - Radiology. 2014 May;271(2):416-25
– reference: 19738517 - South Med J. 2009 Oct;102(10):1032-40
– reference: 24512795 - Magn Reson Imaging. 2014 May;32(4):342-9
– reference: 23151830 - Radiology. 2013 Feb;266(2):531-8
– reference: 23532891 - Clin Cancer Res. 2013 May 1;19(9):2518-27
– reference: 24533873 - Radiology. 2014 Jun;271(3):672-80
– reference: 23018989 - J Magn Reson Imaging. 2013 Jan;37(1):187-93
– reference: 23901319 - Korean J Radiol. 2013 Jul-Aug;14(4):616-25
SSID ssj0023352
Score 2.2073686
Snippet AIM: To determine if efficacy of chemotherapy on liver metastasis of gastrointestinal tract cancer can be predicted by apparent diffusion coefficient(ADC)...
To determine if efficacy of chemotherapy on liver metastasis of gastrointestinal tract cancer can be predicted by apparent diffusion coefficient (ADC) values...
AIM: To determine if efficacy of chemotherapy on liver metastasis of gastrointestinal tract cancer can be predicted by apparent diffusion coefficient (ADC)...
SourceID pubmedcentral
proquest
pubmed
crossref
chongqing
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 3031
SubjectTerms Adult
Aged
Antineoplastic Agents - therapeutic use
Area Under Curve
cancer
Chemotherapy;Liver
Diffusion Magnetic Resonance Imaging
Female
Gastrointestinal Neoplasms - pathology
Humans
imaging;Gastrointestinal
Liver Neoplasms - diagnostic imaging
Liver Neoplasms - drug therapy
Liver Neoplasms - secondary
Male
metastatic
Middle Aged
Observational Study
Predictive Value of Tests
Reproducibility of Results
resonance
ROC Curve
Time Factors
tract
Treatment Outcome
Tumor Burden
tumor;Magnetic
Title Predicting liver metastasis of gastrointestinal tract cancer by diffusion-weighted imaging of apparent diffusion coefficient values
URI http://lib.cqvip.com/qk/84123X/201610/90888889504849544948484956.html
https://www.ncbi.nlm.nih.gov/pubmed/26973399
https://www.proquest.com/docview/1773430145
https://pubmed.ncbi.nlm.nih.gov/PMC4779926
Volume 22
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLWq8cILYuKrfMlIvCCRLnEcu3lEAzRVGgLRiYqXyHbjtmik0DVM8Mpf4Ydyr-2kabdJjD5E0a1zZeWe2Nf28TEhz5mwwiglIqUNjzhHEoBw8toyVyJVkM_hBufjd-LohI8m2aTX-9NhLdVrPTC_Lt1X8j9RBRvEFXfJXiOyrVMwwD3EF64QYbj-U4zfr3CZxRGXT5FfgedBK0j3gsjIDO5XSxSEgO_Ys8pxR6TBQK8w78TTUWqcLovO3QwpJJ-Lr-HYIoty48ppN7XFUEnESU6gFWXCAwExJLeemNPRovAVQNXPlZd6wvmHT6P2OK_P89I3Na_LaNLB6XEwf5zX0eG83rCGFjWaP0AFo1HX7IkDtaqicdMVh5mMRCCVy-8gDY0vTptCPim7rTNjXRTGnbYWOt_ksk4ABXUgcudfZoMfjA0WaApFt_W2d_rBlp0I4yL0UYCHAjwUCzTEuFn_BoPBCGvmhMKwHnetuTX1UHu_GI4eDnbrgAIe82U1-w7vYjsRujC62SXpdrKe8W1yKwxX6CuPvX3SK6s75PcGd9Thjm5wR5eW7uKOOtxRjzuqf9KLuKMBd_h4g7tNMdrBHfW4u0tO3r4ZHx5F4TCPyHAer6Ejs1M5LPlQG2VknGsYp2ep0UKWRmWWlSZNVJ6blCVKOs5zzLWextYkQ5FCVn-P7FXLqnyAbDxtmM6t5anlQhgdT63IcguZaCbVMO2Tl-1bLr550ZYC-XzwyzPosniecZRFcneiTw6aQBQmCOPj-SynxVVA6JMX7RON_6vLPmtiW0DLjctxqiqX9VmRSJlynNHI-uS-j3XrjYlcpjB26BO5hYK2AKrCb_9TLeZOHZ5LmedMPLxGHR-Rm5vv8THZW6_q8gnk2mv91EH9L-UZ3Bk
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Predicting+liver+metastasis+of+gastrointestinal+tract+cancer+by+diffusion-weighted+imaging+of+apparent+diffusion+coefficient+values&rft.jtitle=World+journal+of+gastroenterology+%3A+WJG&rft.au=Zheng%2C+De-Xian&rft.au=Meng%2C+Shu-Chun&rft.au=Liu%2C+Qing-Jun&rft.au=Li%2C+Chuan-Ting&rft.date=2016-03-14&rft.issn=1007-9327&rft.volume=22&rft.issue=10&rft.spage=3031&rft_id=info:doi/10.3748%2Fwjg.v22.i10.3031&rft.externalDBID=n%2Fa&rft.externalDocID=10_3748_wjg_v22_i10_3031
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F84123X%2F84123X.jpg